Barclays
IMMP

Barclays’s Immutep IMMP Stock Holding History

Barclays’s Portfolio IMMP Stock Details IMMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91 Buy
+258
New +$591 ﹤0.01% 4959
2025
Q3 		– Sell
-16
Closed -$26 – 5603
2025
Q2 		$26 Hold
16
– – ﹤0.01% 5138
2025
Q1 		$28 Hold
16
– – ﹤0.01% 5163
2024
Q4 		$35 Buy
+16
New +$32 ﹤0.01% 5208
2021
Q4 		– Sell
-183
Closed -$1K – 4438
2021
Q3 		$1K Hold
183
– – ﹤0.01% 4701
2021
Q2 		$1K Buy
+183
New +$724 ﹤0.01% 4826

Other funds holding IMMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Barclays's IMMP Position: Q1 2026 in Review

Barclays opened a new position in Immutep (IMMP) in Q1 2026: 258 shares worth $91. The stake represents ﹤0.01% of the portfolio and ranks #4959 among its holdings. This is a return to the name: Barclays previously reported a position in IMMP as recently as Q2 2025.

Barclays first reported a position in IMMP in Q2 2021 and has held it in 6 quarters since. The position peaked at $1K in Q3 2021. 26 funds tracked by Wall St. Rank hold IMMP as of Q1 2026.

  • Barclays held 258 shares of Immutep worth $91 as of Q1 2026.
  • Immutep was a new Barclays position in Q1 2026.
  • Immutep made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4959 holding.
  • Barclays first reported a position in Immutep in Q2 2021 and has held it in 6 quarters since.
  • Barclays's Immutep position peaked at $1K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Immutep as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.